These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 9267240)

  • 1. Lichen planus-like histopathologic characteristics in the cutaneous graft-vs-host reaction. Prognostic significance independent of time course after allogeneic bone marrow transplantation.
    Horn TD; Zahurak ML; Atkins D; Solomon AR; Vogelsang GB
    Arch Dermatol; 1997 Aug; 133(8):961-5. PubMed ID: 9267240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Allogeneic peripheral blood stem cell transplantation in patients with early-phase hematologic malignancy: a retrospective comparison of short-term outcome with bone marrow transplantation.
    Lemoli RM; Bandini G; Leopardi G; Rosti G; Bonini A; Fortuna A; Rondelli D; Mangianti S; Motta MR; Rizzi S; Tassi C; Cavo M; Remiddi C; Curti A; Conte R; Tura S
    Haematologica; 1998 Jan; 83(1):48-55. PubMed ID: 9542323
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The lichen planus like and sclerotic phases of the graft versus host disease in man: an ultrastructural study of six cases.
    Janin-Mercier A; Saurat JH; Bourges M; Sohier J; Jean LD; Gluckman E
    Acta Derm Venereol; 1981; 61(3):187-93. PubMed ID: 6167099
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lichenoid graft-vs-host disease in an autologous bone marrow transplant recipient.
    Martin RW; Farmer ER; Altomonte VL; Vogelsang GB; Santos GW
    Arch Dermatol; 1995 Mar; 131(3):333-5. PubMed ID: 7887664
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Outcome of children requiring admission to an intensive care unit after bone marrow transplantation.
    Jacobe SJ; Hassan A; Veys P; Mok Q
    Crit Care Med; 2003 May; 31(5):1299-305. PubMed ID: 12771594
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Female genital tract graft-versus-host disease following allogeneic bone marrow transplantation.
    Spinelli S; Chiodi S; Costantini S; Van Lint MT; Raiola AM; Ravera GB; Bacigalupo A
    Haematologica; 2003 Oct; 88(10):1163-8. PubMed ID: 14555313
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histological evaluation of acute mucocutaneous graft-versus-host disease in nonmyeloablative hematologic stem cell transplants with an observation predicting an increased risk of progression to chronic graft-versus-host disease.
    Bridge AT; Nelson RP; Schwartz JE; Mirowski GW; Billings SD
    Am J Dermatopathol; 2007 Feb; 29(1):1-6. PubMed ID: 17284954
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Treatment with granulocyte colony-stimulating factor after allogeneic bone marrow transplantation for acute leukemia increases the risk of graft-versus-host disease and death: a study from the Acute Leukemia Working Party of the European Group for Blood and Marrow Transplantation.
    Ringdén O; Labopin M; Gorin NC; Le Blanc K; Rocha V; Gluckman E; Reiffers J; Arcese W; Vossen JM; Jouet JP; Cordonnier C; Frassoni F
    J Clin Oncol; 2004 Feb; 22(3):416-23. PubMed ID: 14691124
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endoscopic findings predict the histologic diagnosis in gastrointestinal graft-versus-host disease.
    Cruz-Correa M; Poonawala A; Abraham SC; Wu TT; Zahurak M; Vogelsang G; Kalloo AN; Lee LA
    Endoscopy; 2002 Oct; 34(10):808-13. PubMed ID: 12244503
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic factors of chronic graft-versus-host disease after allogeneic blood stem-cell transplantation.
    Pavletic SZ; Smith LM; Bishop MR; Lynch JC; Tarantolo SR; Vose JM; Bierman PJ; Hadi A; Armitage JO; Kessinger A
    Am J Hematol; 2005 Apr; 78(4):265-74. PubMed ID: 15795914
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Graft-versus-host reaction. Cutaneous manifestations following bone marrow transplantation.
    Hood AF; Soter NA; Rappeport J; Gigli I
    Arch Dermatol; 1977 Aug; 113(8):1087-91. PubMed ID: 18997
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical characteristics of chronic cutaneous graft-versus-host disease in Japanese leukemia patients after bone marrow transplantation: low incidence and mild manifestations of skin lesions.
    Fujii H; Hiketa T; Matsumoto Y; Ohashi M; Miyamura Y; Tanimoto M; Morishima Y; Saito H; Horibe K; Shibata Y
    Bone Marrow Transplant; 1992 Oct; 10(4):331-5. PubMed ID: 1422488
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Keratinocyte apoptosis following bone marrow transplantation: evidence for CTL-dependent and -independent pathways.
    Jerome KR; Conyers SJ; Hansen DA; Zebala JA
    Bone Marrow Transplant; 1998 Aug; 22(4):359-66. PubMed ID: 9722071
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alloreactivity and the predictive value of anti-recipient specific interleukin 2 producing helper T lymphocyte precursor frequencies for alloreactivity after bone marrow transplantation.
    Russell CA
    Dan Med Bull; 2002 May; 49(2):89-108. PubMed ID: 12064093
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chronic graft-versus-host disease after allogeneic peripheral blood progenitor cell or bone marrow transplantation from matched related donors. A case-control study. Spanish Group of Allo-PBT.
    Solano C; Martinez C; Brunet S; Tomás JF; Urbano-Ispizua A; Zuazu J; Ojeda E; Bargay J; Moraleda JM; Bailen A; Sierra J; García-Conde J; Rozman C
    Bone Marrow Transplant; 1998 Dec; 22(12):1129-35. PubMed ID: 9894714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complete remission of lichen-planus-like graft-versus-host disease (GVHD) with extracorporeal photochemotherapy (ECP).
    Gerber M; Gmeinhart B; Volc-Platzer B; Kalhs P; Greinix H; Knobler R
    Bone Marrow Transplant; 1997 Mar; 19(5):517-9. PubMed ID: 9052923
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Normal-looking skin in oncohaematological patients after allogenic bone marrow transplantation is not normal.
    Vassallo C; Brazzelli V; Alessandrino PE; Varettoni M; Ardigò M; Lazzarino M; Borroni G
    Br J Dermatol; 2004 Sep; 151(3):579-86. PubMed ID: 15377343
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prior treatment with alpha-interferon does not adversely affect the outcome of allogeneic BMT in chronic phase chronic myeloid leukemia.
    Zuffa E; Bandini G; Bonini A; Santucci MA; Martinelli G; Rosti G; Testoni N; Zaccaria A; Tura S
    Haematologica; 1998 Mar; 83(3):231-6. PubMed ID: 9573677
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A comparison of related donor peripheral blood and bone marrow transplants: importance of late-onset chronic graft-versus-host disease and infections.
    Anderson D; DeFor T; Burns L; McGlave P; Miller J; Wagner J; Weisdorf D
    Biol Blood Marrow Transplant; 2003 Jan; 9(1):52-9. PubMed ID: 12533742
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Role of skin biopsy to confirm suspected acute graft-vs-host disease: results of decision analysis.
    Firoz BF; Lee SJ; Nghiem P; Qureshi AA
    Arch Dermatol; 2006 Feb; 142(2):175-82. PubMed ID: 16490845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.